These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Dormancy, drug resistance or dependency; some thoughts to ponder. Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116 [No Abstract] [Full Text] [Related]
27. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy. Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413 [TBL] [Abstract][Full Text] [Related]
28. Mycobacterium leprae persisters after treatment with dapsone and rifampicin. Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851 [No Abstract] [Full Text] [Related]
29. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance. Waters MF; Pearson JM; Rees RJ Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850 [No Abstract] [Full Text] [Related]
30. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029 [No Abstract] [Full Text] [Related]
31. The association of pregnancy and leprosy. II. Pregnancy in dapsone-resistant leprosy. Duncan ME; Pearson JM; Rees RJ Lepr Rev; 1981 Sep; 52(3):263-70. PubMed ID: 7035779 [No Abstract] [Full Text] [Related]
32. Survey of primary dapsone-resistant leprosy. Wang HY; Li WZ; Yang LH; Huang HS; Lu WQ; Yu LC Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(3):173-5. PubMed ID: 3321049 [No Abstract] [Full Text] [Related]
33. The diagnosis and management of dapsone-resistant leprosy. Waters MF Lepr Rev; 1977 Jun; 48(2):95-105. PubMed ID: 331001 [No Abstract] [Full Text] [Related]
34. Primary dapsone resistance in Bamako and Chingleput: final report; THELEP. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Lepr Rev; 1987 Sep; 58(3):209-18. PubMed ID: 3312895 [No Abstract] [Full Text] [Related]
35. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results]. Bourland J; Van Loo L; Pattyn SR Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995 [No Abstract] [Full Text] [Related]
36. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses. Browne SG Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048 [No Abstract] [Full Text] [Related]
37. The problem of dapsone-resistant leprosy. Pearson JM Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605 [No Abstract] [Full Text] [Related]
38. Dapsone-resistant leprosy in Jakarta: a preliminary report. Utji R; Kosasih A; Santoso AU Lepr Rev; 1983 Sep; 54(3):193-5. PubMed ID: 6355723 [No Abstract] [Full Text] [Related]